104 related articles for article (PubMed ID: 9377066)
1. Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors.
Shpall EJ
J Hematother; 1997 Aug; 6(4):287-9. PubMed ID: 9377066
[TBL] [Abstract][Full Text] [Related]
2. Regulation of hematopoietic stem cell processing and transplantation.
Rowley SD
Int J Hematol; 2002 Apr; 75(3):237-45. PubMed ID: 11999350
[TBL] [Abstract][Full Text] [Related]
3. Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
Warkentin PI;
Cytotherapy; 2003; 5(4):299-305. PubMed ID: 12944235
[TBL] [Abstract][Full Text] [Related]
4. FAHCT accreditation: common deficiencies during on-site inspections.
Warkentin PI; Nick L; Shpall EJ
Cytotherapy; 2000; 2(3):213-20. PubMed ID: 12042044
[TBL] [Abstract][Full Text] [Related]
5. The blood cell transplant program.
Nelson JP
Semin Oncol Nurs; 1997 Aug; 13(3):208-15. PubMed ID: 9276914
[TBL] [Abstract][Full Text] [Related]
6. Regulation of placental and umbilical cord blood stem cells.
Wagner JE
J Hematother; 1997 Feb; 6(1):1-3. PubMed ID: 9112212
[No Abstract] [Full Text] [Related]
7. Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.
Hurley CK; Foeken L; Horowitz M; Lindberg B; McGregor M; Sacchi N;
Bone Marrow Transplant; 2010 May; 45(5):819-24. PubMed ID: 20173794
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem and progenitor cell transplants: regulation and accreditation.
Warkentin PI
Pediatr Transplant; 2003; 7 Suppl 3():101-8. PubMed ID: 12603702
[No Abstract] [Full Text] [Related]
9. [Analysis of the implementation of a Joint Accreditation Committee of the International Society for Cellular Therapy and European Group for Blood and Marrow Transplantation acreditation in a clinical program of hematopoietic progenitor cell transplantation].
Ferrà C; Jiménez-Lorenzo MJ; Feliu E; Ribera JM;
Med Clin (Barc); 2011 Jun; 137(3):126-30. PubMed ID: 20303546
[No Abstract] [Full Text] [Related]
10. A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts.
Serke S; Johnsen HE
Bone Marrow Transplant; 2001 Mar; 27(5):463-70. PubMed ID: 11313679
[TBL] [Abstract][Full Text] [Related]
11. Quality assurance and good manufacturing practices for processing hematopoietic progenitor cells.
McCullough J
J Hematother; 1995 Dec; 4(6):493-501. PubMed ID: 8846009
[TBL] [Abstract][Full Text] [Related]
12. Quality mammography standards--FDA. Final rule.
Fed Regist; 1997 Oct; 62(208):55852-994. PubMed ID: 10177306
[TBL] [Abstract][Full Text] [Related]
13. [How to handle unexpected biological abnormalities observed in the pre-donation workup for hematopoietic stem cell transplantation: an SFGM-TC report on pre-transplant cytomegalovirus, Epstein-Barr virus, Toxoplasma gondii, or syphilis IgM positive serology test].
Duléry R; Giraud C; Beaumont JL; Bilger K; Borel C; Dhedin N; Thiebaut A; Willems E; Alain S; Alfandari S; Dewilde A; Jouet JP; Milpied N; Yakoub-Agha I;
Pathol Biol (Paris); 2013 Aug; 61(4):155-7. PubMed ID: 24011960
[TBL] [Abstract][Full Text] [Related]
14. Joint position paper on the regulatory approach to hematopoietic cell components in the United States.
J Hematother; 1997 Apr; 6(2):91-2. PubMed ID: 9131437
[No Abstract] [Full Text] [Related]
15. Umbilical cord blood stem cells: my body makes them, but do I get to keep them? Analysis of the FDA proposed regulations and the impact on individual constitutional property rights.
Fredrickson JK
J Contemp Health Law Policy; 1998; 14(2):477-502. PubMed ID: 9693489
[No Abstract] [Full Text] [Related]
16. Implementation of JACIE accreditation results in the establishment of new indicators that unevenly monitor processes contributing to the delivery of hematopoietic SCT.
Caunday O; Agulles O; McGrath E; Empereur F; Stoltz JF; Chabannon C
Bone Marrow Transplant; 2013 Apr; 48(4):604-9. PubMed ID: 23528642
[TBL] [Abstract][Full Text] [Related]
17. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
Fraser GA; Walker II;
Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
[TBL] [Abstract][Full Text] [Related]
19. Family donor care management: principles and recommendations.
van Walraven SM; Nicoloso-de Faveri G; Axdorph-Nygell UA; Douglas KW; Jones DA; Lee SJ; Pulsipher M; Ritchie L; Halter J; Shaw BE;
Bone Marrow Transplant; 2010 Aug; 45(8):1269-73. PubMed ID: 20023708
[TBL] [Abstract][Full Text] [Related]
20. A quality system for transfusion medicine ... and beyond.
Berte LM
MLO Med Lab Obs; 1995 Oct; 27(10):61-4. PubMed ID: 10152037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
